During the past decade, UBMD Obstetrics and Gynecology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UBMD Obstetrics and Gynecology" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UBMD Obstetrics and Gynecology" are "Bladder Irritable" (1 trials), "Bladder Pain Syndrome" (1 trials), "Urinary Frequency/Urgency" (1 trials) and "Vulvodynia" (1 trials). Many other conditions were trialed in "UBMD Obstetrics and Gynecology" in a lesser frequency.

Most popular intervention types in "UBMD Obstetrics and Gynecology" are "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mirabegron" (1 trials) and "Thermographic Imaging and Mechanical Pain Assessment" (1 trials). Other intervention names were less common.

The vast majority of trials in "UBMD Obstetrics and Gynecology" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "UBMD Obstetrics and Gynecology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UBMD Obstetrics and Gynecology, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UBMD Obstetrics and Gynecology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".